Germany โ Medicines with the active ingredient rituximab - in the dosage form infusion solution concentrate (ATC: L01FA01)
By: Public Purchasing Data Service (responsible for the Procurement Office of the BMI)๐ GermanyOpen
Key Information
| Reference | GB-799123-2026 |
|---|
| Deadline | Oct 31, 2028 12:00 AM |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Germany |
|---|
| Address | Bonn, 53119, Germany |
|---|
| Published | Nov 17, 2026 |
|---|
Description
2. Procedure2.1.procedureTitle: Medicines with the active ingredient rituximab - in the dosage form infusion solution concentrate (ATC: L01FA01)Description: The subject of this publication is the conc...
Full details are available after unlocking this tender.